Literature DB >> 20876823

Preexisting antibody response against 2009 pandemic influenza H1N1 viruses in the Taiwanese population.

Chia-Yu Chi1, Ching-Chuan Liu, Chia-Chun Lin, Hsuan-Chen Wang, Yung-Tsung Cheng, Chung-Ming Chang, Jen-Ren Wang.   

Abstract

A novel pandemic influenza H1N1 (pH1N1) virus spread rapidly across the world in 2009. Due to the important role of antibody-mediated immunity in protection against influenza infection, we used an enzyme-linked immunosorbent assay-based microneutralization test to investigate cross-reactive neutralizing antibodies against the 2009 pH1N1 virus in 229 stored sera from donors born between 1917 and 2008 in Taiwan. The peak of cumulative geometric mean titers occurred in donors more than 90 years old and declined sharply with decreasing age. Sixteen of 27 subjects (59%) more than 80 years old had cross-reactive antibody titers of 160 or more against the 2009 pH1N1 virus, whereas none of the donors from age 9 to 49 had an antibody titer of 160 or more. Interestingly, 2 of 51 children (4%) from 6 months to 9 years old had an antibody titer of 40. We further tested the antibody responses in 9 of the 51 pediatric sera to three endemic seasonal influenza viruses isolated in 2006 and 2008 in Taiwan, and the results showed that only the 2 sera from children with antibody responses to the 2009 pH1N1 virus had high titers of neutralizing antibody against recent seasonal influenza virus strains. Our study shows the presence of some level of cross-reactive antibody in Taiwanese persons 50 years old or older, and the elderly subjects who may already have been exposed to the 1918 virus had high titers of neutralizing antibody to the 2009 pH1N1 virus. Our data also indicate that natural infection with the Taiwan 2006 and 2008 seasonal H1N1 viruses may induce a cross-reactive antibody response to the 2009 pH1N1 virus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20876823      PMCID: PMC3008195          DOI: 10.1128/CVI.00212-10

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  16 in total

Review 1.  Correlates of protection: novel generations of influenza vaccines.

Authors:  Guus F Rimmelzwaan; Janet E McElhaney
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

2.  Swine flu. After delays, WHO agrees: the 2009 pandemic has begun.

Authors:  Jon Cohen; Martin Enserink
Journal:  Science       Date:  2009-06-19       Impact factor: 47.728

3.  The global circulation of seasonal influenza A (H3N2) viruses.

Authors:  Colin A Russell; Terry C Jones; Ian G Barr; Nancy J Cox; Rebecca J Garten; Vicky Gregory; Ian D Gust; Alan W Hampson; Alan J Hay; Aeron C Hurt; Jan C de Jong; Anne Kelso; Alexander I Klimov; Tsutomu Kageyama; Naomi Komadina; Alan S Lapedes; Yi P Lin; Ana Mosterin; Masatsugu Obuchi; Takato Odagiri; Albert D M E Osterhaus; Guus F Rimmelzwaan; Michael W Shaw; Eugene Skepner; Klaus Stohr; Masato Tashiro; Ron A M Fouchier; Derek J Smith
Journal:  Science       Date:  2008-04-18       Impact factor: 47.728

Review 4.  Perspectives on pandemics: a research agenda.

Authors:  E D Kilbourne
Journal:  J Infect Dis       Date:  1997-08       Impact factor: 5.226

5.  T cell responses are better correlates of vaccine protection in the elderly.

Authors:  Janet E McElhaney; Dongxu Xie; W David Hager; Mary Beth Barry; Yazhen Wang; Alison Kleppinger; Catherine Ewen; Kevin P Kane; R Chris Bleackley
Journal:  J Immunol       Date:  2006-05-15       Impact factor: 5.422

6.  Protection and compensation in the influenza virus-specific CD8+ T cell response.

Authors:  Richard J Webby; Samita Andreansky; John Stambas; Jerold E Rehg; Robert G Webster; Peter C Doherty; Stephen J Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-29       Impact factor: 11.205

7.  Emergence of a novel swine-origin influenza A (H1N1) virus in humans.

Authors:  Fatimah S Dawood; Seema Jain; Lyn Finelli; Michael W Shaw; Stephen Lindstrom; Rebecca J Garten; Larisa V Gubareva; Xiyan Xu; Carolyn B Bridges; Timothy M Uyeki
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

8.  Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-05-22       Impact factor: 17.586

Review 9.  Emergence and pandemic potential of swine-origin H1N1 influenza virus.

Authors:  Gabriele Neumann; Takeshi Noda; Yoshihiro Kawaoka
Journal:  Nature       Date:  2009-06-18       Impact factor: 49.962

10.  Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918.

Authors:  Martha I Nelson; Cécile Viboud; Lone Simonsen; Ryan T Bennett; Sara B Griesemer; Kirsten St George; Jill Taylor; David J Spiro; Naomi A Sengamalay; Elodie Ghedin; Jeffery K Taubenberger; Edward C Holmes
Journal:  PLoS Pathog       Date:  2008-02-29       Impact factor: 6.823

View more
  16 in total

1.  Individual antibody and T cell responses to vaccination and infection with the 2009 pandemic swine-origin H1N1 influenza virus.

Authors:  Gillian M Air; Jingqi Feng; Tao Chen; Michelle L Joachims; Judith A James; Linda F Thompson
Journal:  J Clin Immunol       Date:  2011-07-06       Impact factor: 8.317

Review 2.  Two years after pandemic influenza A/2009/H1N1: what have we learned?

Authors:  Vincent C C Cheng; Kelvin K W To; Herman Tse; Ivan F N Hung; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

3.  Genetic characterization of avian-origin H3N2 canine influenza viruses isolated from Guangdong during 2006-2012.

Authors:  Heng Wang; Kun Jia; Wenbao Qi; Minze Zhang; Long Sun; Huanbin Liang; Guohao Du; Likai Tan; Zhenwen Shao; Jiahui Ye; Lingshuang Sun; Zhenpeng Cao; Ye Chen; Pei Zhou; Shuo Su; Shoujun Li
Journal:  Virus Genes       Date:  2013-03-06       Impact factor: 2.332

4.  The age-specific cumulative incidence of infection with pandemic influenza H1N1 2009 was similar in various countries prior to vaccination.

Authors:  Heath Kelly; Heidi A Peck; Karen L Laurie; Peng Wu; Hiroshi Nishiura; Benjamin J Cowling
Journal:  PLoS One       Date:  2011-08-05       Impact factor: 3.240

5.  Pandemic influenza due to pH1N1/2009 virus: estimation of infection burden in Reunion Island through a prospective serosurvey, austral winter 2009.

Authors:  Koussay Dellagi; Olivier Rollot; Sarah Temmam; Nicolas Salez; Vanina Guernier; Hervé Pascalis; Patrick Gérardin; Adrian Fianu; Nathanael Lapidus; Nadège Naty; Pablo Tortosa; Karim Boussaïd; Marie-Christine Jaffar-Banjee; Laurent Filleul; Antoine Flahault; Fabrice Carrat; Francois Favier; Xavier de Lamballerie
Journal:  PLoS One       Date:  2011-09-29       Impact factor: 3.240

6.  Emerged HA and NA mutants of the pandemic influenza H1N1 viruses with increasing epidemiological significance in Taipei and Kaohsiung, Taiwan, 2009-10.

Authors:  Chuan-Liang Kao; Ta-Chien Chan; Chu-Han Tsai; Kuan-Ying Chu; Shu-Fang Chuang; Chang-Chun Lee; Zheng-Rong Tiger Li; Ko-Wen Wu; Luan-Yin Chang; Yea-Huei Shen; Li-Min Huang; Ping-Ing Lee; Chinglai Yang; Richard Compans; Barry T Rouse; Chwan-Chuen King
Journal:  PLoS One       Date:  2012-02-06       Impact factor: 3.240

7.  The antigenic evolution of influenza: drift or thrift?

Authors:  Paul S Wikramaratna; Michi Sandeman; Mario Recker; Sunetra Gupta
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-04       Impact factor: 6.237

8.  The roles of competition and mutation in shaping antigenic and genetic diversity in influenza.

Authors:  Daniel Zinder; Trevor Bedford; Sunetra Gupta; Mercedes Pascual
Journal:  PLoS Pathog       Date:  2013-01-03       Impact factor: 6.823

9.  2009 A(H1N1) seroconversion rates and risk factors among the general population in Vientiane Capital, Laos.

Authors:  Alexia Kieffer; Phimpha Paboriboune; Pascal Crépey; Bruno Flaissier; Vimalay Souvong; Nicolas Steenkeste; Nicolas Salez; François-Xavier Babin; Christophe Longuet; Fabrice Carrat; Antoine Flahault; Xavier de Lamballerie
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

10.  Pre-existing immunity with high neutralizing activity to 2009 pandemic H1N1 influenza virus in Shanghai population.

Authors:  Xiaoqing Liu; Yuan Liu; Yanjun Zhang; Zhihui Chen; Ziwei Tang; Qingqiang Xu; Yue Wang; Ping Zhao; Zhongtian Qi
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.